RAI1 Gene Acts as a Brake on Human Brain Development, Study Shows
Researchers using human embryonic stem cells found that the RAI1 gene acts as a molecular brake that controls the pace of neurodevelopmental gene expression, and its loss accelerates brain maturation. RAI1 is already known to be haploinsufficient in Smith-Magenis Syndrome (SMS), a neurodevelopmental disorder involving cognitive impairment and autistic features. The findings suggest that disrupted developmental timing, not just gene dysfunction per se, may be a key mechanism underlying SMS and potentially other neurodevelopmental conditions.
A new preprint study published on bioRxiv used isogenic heterozygous and homozygous RAI1 loss-of-function human embryonic stem cell lines to investigate how the RAI1 gene regulates brain development. Longitudinal transcriptome analysis during in vitro cortical development showed that RAI1 deficiency causes accelerated progression of developmental gene expression, including the premature activation of synaptic genes. Single-cell RNA sequencing further revealed that RAI1-deficient neuroprogenitors transiently adopt a mesoderm-like gene expression signature before shifting toward pro-neuronal maturation in postmitotic neurons, an unexpected lineage deviation. The developmental acceleration was further amplified during NGN2-induced excitatory neuron differentiation, pointing to a functional interaction between RAI1 and NGN2-driven transcriptional programs. The authors conclude that RAI1 serves a dual role: suppressing the mesodermal lineage program and slowing the tempo of human neurodevelopmental gene expression, a property that may be relevant to the unusually extended timeline of human brain development and its link to advanced cognition.
What's missing
As a preprint, this study has not yet undergone peer review. The experiments were conducted entirely in vitro using stem cell-derived models, and it remains unclear whether the observed transcriptional acceleration translates to functional or structural differences in neurons, or how findings would generalize to in vivo human brain development. The study does not address whether the mesoderm-like gene expression signature has any downstream functional consequence, nor does it examine potential therapeutic implications for Smith-Magenis Syndrome patients.
What different sources said
- bioRxivCenter
RAI1 safeguards fidelity and tempo of human neurodevelopmental gene expression
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.